Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_assertion description "[We investigated the NADPH oxidase activity, cytochrome b558 content, and gene expression of gp91-phox and p47-phox in normal Epstein-Barr-virus (EBV)-transformed B lymphocytes, compared to EBV-transformed B lymphocytes from patients with X-linked chronic granulomatous disease (CGD), normal peripheral blood neutrophils or mononuclear cells, and the A301 or C8166 lymphoblastoid cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_assertion evidence source_evidence_literature NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_assertion SIO_000772 9851826 NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_assertion wasDerivedFrom befree-20150227 NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_assertion wasGeneratedBy ECO_0000203 NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP352226.RARx2r2mbY3xl2Sa-ru89mqsWwdcuDHKWgODuC1WFJ6yI130_provenance.